Correlation Between Alger Health and Evaluator Moderate

Can any of the company-specific risk be diversified away by investing in both Alger Health and Evaluator Moderate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alger Health and Evaluator Moderate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alger Health Sciences and Evaluator Moderate Rms, you can compare the effects of market volatilities on Alger Health and Evaluator Moderate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alger Health with a short position of Evaluator Moderate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alger Health and Evaluator Moderate.

Diversification Opportunities for Alger Health and Evaluator Moderate

0.34

Correlation Coefficient

Alger Health  Evaluator Moderate

Weak diversification

The 3 months correlation between Alger and Evaluator is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Alger Health Sciences and Evaluator Moderate Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Moderate Rms and Alger Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alger Health Sciences are associated (or correlated) with Evaluator Moderate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Moderate Rms has no effect on the direction of Alger Health i.e., Alger Health and Evaluator Moderate go up and down completely randomly.

Pair Corralation between Alger Health and Evaluator Moderate

Assuming the 90 days horizon Alger Health is expected to generate 47.28 times less return on investment than Evaluator Moderate. In addition to that, Alger Health is 1.66 times more volatile than Evaluator Moderate Rms. It trades about 0.0 of its total potential returns per unit of risk. Evaluator Moderate Rms is currently generating about 0.31 per unit of volatility. If you would invest  1,054  in Evaluator Moderate Rms on April 26, 2025 and sell it today you would earn a total of  101.00  from holding Evaluator Moderate Rms or generate 9.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Alger Health Sciences  vs.  Evaluator Moderate Rms

Alger Health Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alger Health Sciences has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Alger Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Evaluator Moderate Rms

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Moderate Rms are ranked lower than 24 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak primary indicators, Evaluator Moderate may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Alger Health and Evaluator Moderate

The main advantage of trading using opposite Alger Health and Evaluator Moderate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alger Health position performs unexpectedly, Evaluator Moderate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Moderate will offset losses from the drop in Evaluator Moderate's long position.

The idea behind Alger Health Sciences and Evaluator Moderate Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.